Genmab's EPCORE DLBCL-1 Phase 3 trial posts results after primary completion in October 2026Nov 3Trial updateAbbVieepcoritamab-bysp
BMS: Reblozyl label supplement approved; GLORY CAR-T trial and BMS-986485 Phase 1 postedOct 22Weekly roundup, 4 itemsBristol Myers Squibbliso-celUpdated
Sign inSign in